Kappa Bioscience
Company

About us

At Kappa Bioscience we are proud to offer you high purity vitamin K2 as menaquinone-7 (MK-7).  As the innovative leader and first mover of vitamin K2 MK-7, we have extensive knowledge about vitamins and are currently the only vendor with vitamin K2 as pure MK-7 in various formulations.

Founded in December 2006, Kappa Bioscience is a Norwegian based entity that takes pride in following a traditional vitamin production process with propriety and innovative new steps.  One of our core assets is the patent covering the production of pure vitamin K2 as menaquinone‑7.

Our main focus is to develop vitamin K2 for the food supplement and fortified foods market.

Vitamin K2 is currently gaining momentum across the world and as it does, we intend to continue to serve the market with pure and stable forms of MK-7 products.

All of our products have been developed in close collaboration with highly qualified Norwegian and international scientists, who have been able to successfully accomplish the difficult process of producing menaquinone-7.

We are proud to launch the first man-made menaquinone-7 in its natural form - as K2VITAL®.

  • Our research is conducted globally

  • Production is established in the US as well as Europe

  • Marketing and sales activities are managed from Norway and the US.

eye

Our Vision

Kappa Bioscience has the vision to deliver vitamin K2 to the mass market, making it available to everybody, everywhere.

rocket

Mission statement

We believe our product – Vitamin K2 MK-7 and our mission is to provide everyone from manufacturers to consumers with a pure, reliable and safe product.  We take pride in delivering everyone with a quality product for improving health.

compass

Our values

The company values shall guide each individual employee’s behavior and be the basis for creating a transparent and collaborative company culture.  Kappa Bioscience’s core values are:

Bravery / Openness / Activeness


Management

Egil Greve

President and CEO
DVM, MBA

Egil is an entrepreneur with broad executive experience from building up companies and business units within the multinational companies Norsk Hydro ASA, Yara International ASA and AKZO Nobel. He also headed several SMBs including NattoPharma ASA before he was asked to build up Kappa Bioscience in 2009.

egil.greve@kappabio.com

Kai Schröder

VP Finance & Operations
MSc (Management & Economics), INSEAD EMP

Kai is an executive with experience from international companies such as GE Healthcare, Philip Morris International and Porsche in functions ranging from Manufacturing & Supply Chain to General Management. He accumulated extensive know-how in the areas of Managing P&Ls, Commercial Management and Leadership, Finance and Strategy as well as Sales & Operations Planning.

kai.schroeder@kappabio.com

Trygve Bergeland

VP Science & Product Development
PhD

Trygve has a broad experience in research and documentation within the nutraceutical and pharmaceutical industry. Before joining Kappa Bioscience, Trygve was responsible for the clinical documentation program in Aker BioMarine. He has generated extensive experience from management of clinical research in Clavis Pharma and LINK Medical Research.

trygve.bergeland@kappabio.com

Inger Reidun F. Aukrust

Vice President R&D & Chemistry
PhD in Organic Chemistry

More than 25 years of experience within medicinal chemistry and custom synthesis from SINTEF and Synthetica. Founder of Synthetica and Kappa Bioscience.

ingerreidun.aukrust@kappabio.com

Jörg Büttinghaus

Vice President Sales & Marketing
MBA

Jörg is responsible for the groups global sales and marketing organization. He has been a member of the nutraceutical industry for more than 15 years, during which time he was involved in the introduction of several successful specialities including PressCAL®, AlgaeCal®, NEM®, Calcified Atlantic Seaweed® and K2VITAL®.

Joerg.buettinghaus@kappabio.com


History

The origin of K2VITAL® dates back to 2006, when Norwegian researcher, Dr Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans Vitamin K2, MK-7, using natural compounds such as geraniol and farnesol in a strictly controlled synthesis process.

The significance of the process for all-trans vitamin K2 MK-7 has been recognised and patented. For vitamin K’s, two stereo chemical versions can exist: cis and trans forms of the molecule. The cis form remains biologically inactive, while the trans form has a full biological potential. Commercially available vitamin K2 products may contain both forms.


Certifications


Distributors

Kappa is proud to work and collaborate with the leading nutritional supplements distributors in regions that span the globe. We invite you to contact our distributors directly to learn about K2VITAL® and the Kappa product portfolio, or contact Kappa directly and we will make an introduction.

DistributorCountryRegionOperative in charge
PathwayAustralia and New ZealandAsiaWayne Coote (Email)
PharmachemIndiaAsiaPradeep Anaokar (Email)

Connell Bros

VietnamAsiaThanh Nguyen Dai Chi (Email)
Epic IngredientsMalaysiaAsiaMr Jeffrey Aw (Email)
Connell BrosTaiwanAsiaMs Monika Chang (Email)
PhytonetPhilippinesAsiaHelen Grace Basia (Email)
Phytonet Indonesia

Asia

Mr Noviar Antoni (Email)
Velpha ChemicalsPakistanAsia

Mr Ali Hassni (Email)

Ask Intercity Co LtdJapanAsiaMr. Fumiko Hiroshi (Email)
Mahban GroupIranMiddle EastDr Orandi (Email)
IVCChinaAsiaChen Wu (Email)
FaravelliItalyEuropeTiziana Ferrari (Email)
KUKEastern EuropeEuropeMichal Stibor (Email)
PhytonetTurkeyEuropeSelim Ay (Email)
PhytonetSerbiaEuropeBojan Pavlovic (Email)
Safic AlcanSpainEuropeMercedes Carillo (Email)
Safic AlcanFranceEuropeCharlotte Delarue (Email)
Solo GroupSouth AfricaAfricaDean Hall (Email)
ChemroyCanadaAmericaJim Bornhold (Email)
Tovani Benzaquen IngredientesBrazilAmericaVinicius Uehara (Email)
Xsto SolutionsUSAAmericaFrancis Foley (Email)

Press

  • Company
  • Vitamin K2

Formulation next-generation vitamin k2

More Information

 

Vitamin manufacturer Kappa acquires European distributor PPM

More Information

Kappa buys European distributor

More Information

Kappa Bioscience Creates End-to-End Solution with Acquisition of ppm.Ingredients

More Information

Kappa Bioscience to Acquire European Distributor ppm.Ingredients

More Information

Kappa Bioscience announces vitamin K2 stability project

More Information

New study demonstrates vitamin K2 MK-7 bioequivalence for the two primary manufacturing approaches

More Information

Synthesis-derived MK-7 is Bioequivalent to Fermentation-derived MK-7

More Information

Kappa Bioscience unveils first-in-class vitamin K2 MK-7 formulations book at Vitafoods 2016

More Information

Vitamin K2 MK-7: A stability challenge, a market study

More Information

Unfulfilled Promises: The Need for Ethical K2 Labelling

More Information

Kappa debuts double-coated vitamin K2

More Information

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Deichstrasse 29 | 20459 Hamburg
Germany

Headquarter
Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo
Norway

+49 40 6094087 0